Clinical Trial Update: Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety of multiple doses of intranasal naloxone in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Narcan Nasal Spray (Naloxone)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Opioid Overdose | Phase 1 | Status: COMPLETED